Virgin Orbit’s LauncherOne rocket is displayed in Times Square in New York.
CNBC | Michael Sheetz
Check out the companies making the biggest moves of the afternoon:
virgin orbit – The satellite launch services company fell 13.99% a day after confirming its first launch from the United Kingdom on Monday failed to reach class, The mission was Virgin Orbit’s sixth to date, and its second launch failure.
Danaher — Shares of Danaher soared 4.64% after the maker of medical, industrial and commercial products issued upbeat guidance for fourth-quarter non-GAAP core revenue. The company now expects growth in high single-digit percentage on a year-to-year basis. It had previously forecast a flat to low single-digit percentage decline.
Sotera Health Stock soars 99.65% a day after Sotera Health announced settlement More than 870 cases related to exposure to ethylene oxide, a carcinogen, from its Willowbrook facilities. The company, which said the settlement was not an admission that the emissions posed a safety hazard, agreed to pay $408 million.
warner bros discovery Media company shares jump 8.18% after Bank of America Added stock to list “US1”, The Wall Street firm said it is stable on the long-term potential and views the current risk/reward as “highly attractive”.
coinbase – Shares surge 12.96% after cryptocurrency exchange plans to share trim its workforce from 20%. The cuts come after Coinbase laid off 18% of its employees in June as crypto prices plummeted, and its stock plummeted.
bed Bath and Beyond — The retailer jumped 27.78%. This step comes after income call, In which the leadership said that the company has suffered a bigger loss than expected. A few days ago, the company warned of possible bankruptcy.
Oak Street Health Shares of Oak Street Health, a health care company that manages primary care centers for Medicare patients, later jumped 27.47%. Bloomberg reported he cvs Looking for a deal to buy it for more than $ 10 billion.
Regeneron Pharmaceuticals — Shares rose 2.71%, a day after shares fell nearly 7.7% on news that a switch to an off-label competitor in the final quarter of 2022 hurt sales of the pharmaceutical company’s Ilya drug Was. On Tuesday, CEO Leonard Schleifer told CNBC that the activity was “temporary” and should have no impact on Eela’s long-term trajectory.
frontline After this the shares of the shipping company jumped 25.68% frontline announced that it was terminating an agreement to tie-up with Euronav. The plan called for Frontline to acquire Euronav in an all-stock deal. CEO Lars Barstedt said in a statement that both shippers “are already enjoying massive economies of scale.”
bumble – The dating app’s stock rose 7.33% upgrade to overweight From Sector Weight at KeyBanc Capital Markets. The firm said it is growing more confident in the company’s ability to capitalize on online dating trends and grow revenue.
Illumina Shares were down 6.2% in midday trading. The gene-sequencing technology company on Tuesday appealed an EU antitrust order blocking its merger deal with biotech firm Grail. A day earlier, Illumina said it expects its 2023 fiscal year consolidated revenue to come in between $4.9 billion and $5.035 billion, versus a StreetAccount estimate of $5.005 billion.
curevac — The biopharmaceutical company gained 20.56% after it said it plans to advance patient trials of its mRNA vaccines for COVID-19 and flu. CureVac also announced Sanofi veteran Alexander Zander Will become CEO in April.
Agilent Technologies – Shares rose 5.26% a day after the company announced $2 billion share repurchase program. Agilent also said it was investing $725 million To double the manufacturing capacity.
on semiconductor – The semiconductor stock dropped 0.59% after William Blair downgraded it to Market Perform. Analysts said Semiconductor GT continues to struggle with advanced technologies and its silicon carbide yields are half of their origination assumptions.
dish network — The Satellite TV Company declined 6.26%. Goldman Sachs on Tuesday restored its neutral rating, noting that while the company is in a position to acquire shares, it faces significant execution risk and an acceleration of cord-cutting. The firm’s $14 price target is down 11.5% from Monday’s close.
— CNBC’s Samantha Subin, Alex Haring, Yoon Lee, Tanaya Machel, Carmen Reinicke, Jesse Pound and Michael Bloom contributed reporting.